Superstring Capital Management LP, a Delaware limited partnership (“Superstring”, the
“Firm”, “we”, “us”, “Investment Manager”, or “our”), commenced operations in 2019.
Superstring was founded by Ting Guo, who is the sole owner of the Firm. As of December
31, 2023, Superstring’s regulatory assets under management were approximately USD
$371,100,000, all managed on a discretionary basis.
Superstring offers investment advisory services on a discretionary basis to Superstring Capital
Master Fund LP, a Cayman Islands exempted limited partnership and two feeder funds,
Superstring Capital Onshore Fund LP, a Delaware limited partnership and Superstring Capital
Offshore Fund Ltd, a Cayman Islands exempted company (collectively the “Hedge Fund”).
The Firm also manages the Superstring Private Opportunities Fund I LP, a Delaware limited
partnership, and a feeder fund, the Superstring Private Opportunities Offshore Fund I LP, a
Cayman Islands exempted limited partnership (collectively the “PE Fund”). The Hedge Fund
and PE Fund are collectively referred to as the “Funds”. Superstring is also the investment
advisor to three separately managed accounts, which generally employ the same strategy as
the Hedge Fund.
The investment objective of the Firm is to achieve long-term capital appreciation, primarily
through long and short
public equity and equity-related investments as well as private
investments in healthcare companies with material operations or opportunities in the China
market. Such investments may include biotechnology, pharmaceuticals, medical devices and
tools, healthcare services, healthcare information technology and other healthcare-related
companies. Superstring applies a rigorous bottom-up, fundamental and long-term investment
approach that leverages the Firm’s deep knowledge of industry dynamics and the regulatory
framework within the China healthcare ecosystem. From time to time, Superstring buys
securities on margin, borrows from brokers, banks and others on a secured or unsecured
basis, and employs options, short sales, swaps, forwards and other derivative instruments as
Superstring deems appropriate.
Superstring bases its advice to each client on the investment objectives and restrictions, if any,
set forth in the applicable organizational document, limited partnership agreement, investment
management agreement, offering memorandum and/or subscription agreement, as the case
may be, of each client (each, a “Fund Document” and, collectively, the “Fund
Documents”). The Funds are not tailored to any particular private fund investor (each an
“Investor”).
Superstring does not participate in wrap fee programs.